As indicated by the National Institute of Neoplastic Diseases, prostate cancer is the leading cause of death in our country’s male population. According to the World Cancer Observatory (GLOBOCAN), more than 8 thousand cases are diagnosed each year in Peru, of which it is estimated that 70% are detected at an advanced stage.
This 16 November is celebrated as the World Day to Fight Prostate Cancer, which seeks to raise awareness among the male population about the pathology and the importance of periodic urological control, in addition to providing guidance on various diagnostic methods.
This is why it becomes relevant to raise awareness among the male population about this disease and break the taboos that still exist around it. In that sense, through the TENA brand, Dr. Felipe Balbontín, urologist and president of the Chilean Corporation against Prostate Cancer, has shared some points to consider. Early diagnosis is the key
One of the major methods for early diagnosis of prostate cancer is a blood test To measure prostate-specific antigen levels. This test has become one of the main early detection resources. Based on its results, it is evaluated whether another diagnostic method is necessary for the patient.
Side effects? Due to fear of prostate screening and possible side effects like impotence and urinary incontinence, people postpone seeking help from specialists and as a result, put off detecting possible cancers. However, early diagnosis can offer less invasive treatment, which significantly reduces the risk of side effects such as incontinence and impotence resulting from surgery.
Possible side effects and how to treat them
One of the side effects of more radical treatments can be loss of control or cause urinary incontinence. This, he assures, has a direct impact on the quality of life of patients. However, for this situation it is important to choose good quality products with innovative technology, which allow men to feel comfortable and safe, but above all facilitate their mobility.
Finally, it is important to know that a cancer diagnosis does not necessarily indicate impotence and incontinence: “The taboo associated with this disease must be eliminated. To end the silence associated with this condition, men should undergo prostate antigen test from the age of 50 onwards,” concluded the doctor.